title: [Complete remission in acute myeloblastic leukemia (M0) after treatment with rhG-CSF].
abstract: A 57-year-old man was admitted because of fever and night sweat. The bone marrow was hypercellular with 86.4% blast cells. The diagnosis of AML (M0) was made, because the blast cells were negative for peroxidase stain and had CD13 and no lymphoid antigens in marker analysis. The patient was treated with BH-AC.TMP, BH-AC.MVP and low dose Ara-C without any hematological improvement, and even additional treatment with medium dose Ara-C resulted in 66.4% blast cells in the bone marrow. Subsequent administration of rhG-CSF (150 micrograms/day) by continuous intravenous infusion resulted in the decrease of the blast cells in the bone marrow to a level that was evaluated as complete remission. He remains in complete hematological remission at present. As shown in this case, rhG-CSF might be an effective agent for the treatment of AML, even if the mechanism of its effectiveness is unclear at present. Further clinical studies should will supply useful information to analyze the pathophysiology of AML.
authors.affiliation: First Division of Internal Medicine, Kyoto University.
authors.forename: A
authors.initials: A
authors.lastname: Maeda
authors.forename: N
authors.initials: N
authors.lastname: Yoshinaga
authors.forename: H
authors.initials: H
authors.lastname: Hirata
authors.forename: K
authors.initials: K
authors.lastname: Asagoe
authors.forename: M
authors.initials: M
authors.lastname: Nohgawa
authors.forename: K
authors.initials: K
authors.lastname: Takano
authors.forename: N
authors.initials: N
authors.lastname: Harakawa
authors.forename: Y
authors.initials: Y
authors.lastname: Nakabo
authors.forename: A
authors.initials: A
authors.lastname: Takahashi
authors.forename: K
authors.initials: K
authors.lastname: Yamamoto
mesh_terms: D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor